Dis-Chem Pharmacies Limited (JSE:DCP)

South Africa flag South Africa · Delayed Price · Currency is ZAR · Price in ZAc
3,497.00
-296.00 (-7.80%)
May 29, 2026, 5:02 PM SAST
Market Cap29.97B +7.6%
Revenue (ttm)42.83B +9.3%
Net Income978.89M -17.0%
EPS1.14 -17.0%
Shares Out 856.96M
PE Ratio30.65
Forward PE20.68
Dividend0.59 (1.68%)
Ex-Dividend DateJun 17, 2026
Volume4,473,727
Open3,600.00
Previous Close3,793.00
Day's Range3,204.00 - 3,600.00
52-Week Range3,020.00 - 3,900.00
Beta0.35
AnalystsHold
Price Target3,885.00 (+11.1%)
Earnings DateMay 29, 2026

About Dis-Chem Pharmacies

Dis-Chem Pharmacies Limited, together with its subsidiaries, engages in the retail and wholesale of healthcare products and pharmaceuticals in South Africa. The company operates through two segments, Retail and Wholesale. It owns and operates a chain of retail stores that offers various products, including dispensary, personal care and beauty, healthcare and nutrition, baby care, and other products. The company also provides pharmaceutical, health, and front shop products in the wholesale market. In addition, it offers customer loyalty programs... [Read more]

Sector Healthcare
Founded 1978
Employees 20,000
Stock Exchange Johannesburg Stock Exchange
Ticker Symbol DCP
Full Company Profile

Financial Performance

In fiscal year 2026, Dis-Chem Pharmacies's revenue was 42.83 billion, an increase of 9.33% compared to the previous year's 39.17 billion. Earnings were 978.89 million, a decrease of -17.03%.

Financial Statements

News

Dis-Chem Pharmacies Earnings Call Transcript: H2 2026

Better Rewards and digital transformation drove strong revenue and market share gains, with total income margin improving despite significant ecosystem investment and restructuring. Retail and wholesale segments both grew, and the Store of the Future format is set to accelerate expansion.

2 days ago - Transcripts

Dis-Chem Pharmacies Annual report: H2 2026

Dis-Chem Pharmacies has published its H2 2026 annual report on May 29, 2026.

2 days ago - Filings

Dis-Chem Pharmacies Slides: H2 2026

Dis-Chem Pharmacies has posted slides in relation to its H2 2026 quarterly earnings report, which was published on May 29, 2026.

2 days ago - Filings

Dis-Chem Pharmacies Earnings Call Transcript: H1 2026

Group delivered strong H1 FY2026 results with 8.7% revenue growth, 9.9% total income growth, and 25.8% core retail profitability increase (excluding ecosystem investments). Major investments in digital, loyalty, and healthcare ecosystem are driving transformation and future growth.

7 months ago - Transcripts

Dis-Chem Pharmacies Quarterly report: H1 2026

Dis-Chem Pharmacies has published its H1 2026 quarterly earnings report on October 30, 2025.

7 months ago - Filings

Dis-Chem versus Clicks

South Africa’s two largest pharmacy chains, Dis-Chem and Clicks, are fighting for market share. Here is the scoreboard.

1 year ago - Daily Investor